21
Participants
Start Date
September 30, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Bipolar Radiofrequency Focal Ablation
Men identified as having suspicious regions on a pre-biopsy mpMRI will be considered for enrollment. Following an MRI-US targeted biopsy of the prostate, men testing positive will be eligible for enrollment. All men enrolled in the study will undergo focal radiofrequency ablation and evaluated in follow-up.
Smilow Comprehensive Prostate Cancer Center, New York
Trod Medical N.V.
INDUSTRY
NYU Langone Health
OTHER